Tanja Obradovic, Therapeutic Strategy Lead, Oncology at Novotech, shared a post on LinkedIn:
“I’m very excited to share that I’m starting a new position as Therapeutic Strategy Lead, Oncology at Novotech.
Appreciate great opportunity to work with a highly experienced and mission-driven team to deliver oncology clinical studies for emerging and established Biopharma seeking success-oriented CRO partnerships to drive effective and innovative study and program solutions to bring novel cancer therapies to so many patients in need.”
You can also read:
Tanja Obradovic: Eventful 2025 Year for Cancer Drugs-45 New or Accelerated Approvals by FDA